Psychotropic Polypharmacy Among Youths Enrolled in Medicaid

Authors:

Abstract
Concomitant use of medications for attention-deficit/hyperactivity disorder (ADHD), antipsychotics, mood-stabilizing anticonvulsants, and antidepressants is referred to as psychotropic polypharmacy.1 Over the past 2 decades, psychotropic polypharmacy in youths increased, raising safety concerns.2-4 Our goal was to examine trends from 2015 to 2020 in psychotropic polypharmacy among youths aged 17 years or younger who were enrolled in Medicaid to identify temporal changes and characteristics associated with psychotropic polypharmacy.